C1307
Cyclo(D-Glu-Ala-D-allo-Ile-Leu-D-Trp)
≥97% (HPLC)
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
Informazioni su questo articolo
Formula empirica (notazione di Hill):
C31H44N6O7
Numero CAS:
Peso molecolare:
612.72
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiassay
≥97% (HPLC)
form
solid
composition
Peptide content, >60%
storage temp.
−20°C
SMILES string
CCC(C)C1NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(C)C)NC1=O
InChI
1S/C31H44N6O7/c1-6-17(4)26-31(44)36-23(13-16(2)3)29(42)35-24(14-19-15-32-21-10-8-7-9-20(19)21)30(43)34-22(11-12-25(38)39)28(41)33-18(5)27(40)37-26/h7-10,15-18,22-24,26,32H,6,11-14H2,1-5H3,(H,33,41)(H,34,43)(H,35,42)(H,36,44)(H,37,40)(H,38,39)
InChI key
UMKHUVRCCMAOBN-UHFFFAOYSA-N
Biochem/physiol Actions
Selective ETA endothelin receptor antagonist.
Classe di stoccaggio
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
N Syed et al.
The Journal of urology, 159(2), 563-566 (1998-07-02)
Endothelin-1 (ET-1), a peptide produced by the vascular endothelium, causes profound renal vasoconstriction by binding to ET-A receptors. The present study examined the renal actions of ET-1 after ET-A receptors were blocked by BE-18257B to unmask the functions of ET-B
T Hiramatsu et al.
Circulation, 92(9 Suppl), II400-II404 (1995-11-01)
Prior studies suggest an important role for coronary endothelium in ischemia/reperfusion (I/R) injury. Decreased endothelial release of the vasodilator nitric oxide occurs after I/R, but the role of the endothelium-derived vasoconstrictor endothelin-1 (ET-1) in I/R is unknown. We measured plasma
M Coles et al.
Journal of medicinal chemistry, 36(18), 2658-2665 (1993-09-03)
The selective endothelin antagonist cyclo(D-Glu-L-Ala-D-allo-Ile-L-Leu-D-Trp, BE18257B) has been synthesized via solid-phase methods and its solution conformation determined by NMR spectroscopy and simulated annealing calculations based on NOE constraints. Additional information used in the structure determination included coupling constants and chemical-shift